| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | AZD7762 | GDSC1000 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | GDC-0941 | GDSC1000 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | embelin | GDSC1000 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | -0.0096 | 0.8 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | 0.013 | 0.8 |
| mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | 0.0095 | 0.8 |
| mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |